Tue, December 7, 2010
Mon, December 6, 2010
Fri, December 3, 2010
Thu, December 2, 2010
Wed, December 1, 2010
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
2005 Certification
Mon, November 29, 2010
Thu, November 25, 2010
Wed, November 24, 2010
Tue, November 23, 2010
Mon, November 22, 2010
Sat, November 20, 2010
Fri, November 19, 2010
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010

SuperGen to Present at New York Society of Security Analystsa? Biotech & Specialty Pharmaceuticals Conference on November 30th


//health-fitness.news-articles.net/content/2010/ .. pharmaceuticals-conference-on-november-30th.html
Published in Health and Fitness on Tuesday, November 23rd 2010 at 3:20 GMT by Market Wire   Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at The New York Society of Security Analystsa™ 14th Biotech & Specialty Pharmaceuticals Industry Investor Conference on Tuesday, November 30th in New York.

SuperGen's presentation will begin at 9:35 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].


Publication Contributing Sources